RT Journal Article
SR Electronic
T1 Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.07.21249410
DO 10.1101/2021.01.07.21249410
A1 Thomas G. Beach
A1 Aryck Russell
A1 Lucia I. Sue
A1 Anthony J. Intorcia
A1 Michael J. Glass
A1 Jessica E. Walker
A1 Richard Arce
A1 Courtney M. Nelson
A1 Tony Hidalgo
A1 Glenn Chiarolanza
A1 Monica Mariner
A1 Alex Scroggins
A1 Joel Pullen
A1 Leslie Souders
A1 Kimberly Sivananthan
A1 Niana Carter
A1 Megan Saxon-LaBelle
A1 Brittany Hoffman
A1 Angelica Garcia
A1 Michael Callan
A1 Brandon E. Fornwalt
A1 Jeremiah Carew
A1 Jessica Filon
A1 Brett Cutler
A1 Jaclyn Papa
A1 Jasmine R. Curry
A1 Javon Oliver
A1 David Shprecher
A1 Alireza Atri
A1 Christine Belden
A1 Holly A. Shill
A1 Erika Driver-Dunckley
A1 Shyamal H. Mehta
A1 Charles H. Adler
A1 Chadwick F. Haarer
A1 Thomas Ruhlen
A1 Maria Torres
A1 Steve Nguyen
A1 Dasan Schmitt
A1 Mary Fietz
A1 Lih-Fen Lue
A1 Douglas G. Walker
A1 Joseph P. Mizgerd
A1 Geidy E. Serrano
YR 2021
UL http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249410.abstract
AB There has been a markedly renewed interest in factors associated with pneumonia, a leading cause of death worldwide, due to its frequent concurrence with pandemics of influenza and Covid-19 disease. Reported predisposing factors to both bacterial pneumonia and pandemic viral lower respiratory infections are wintertime occurrence, older age, obesity, pre-existing cardiopulmonary conditions and diabetes. Also implicated are age-related neurodegenerative diseases that cause parkinsonism and dementia. We investigated the prevalence of autopsy-proven pneumonia in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND), a longitudinal clinicopathological study, between the years 2006 and 2019 and before the beginning of the Covid-19 pandemic. Of 691 subjects dying at advanced ages (mean 83.4), pneumonia was diagnosed postmortem in 343 (49.6%). There were 185 subjects without dementia or parkinsonism while clinicopathological diagnoses for the other subjects included 319 with Alzheimer’s disease dementia, 127 with idiopathic Parkinson’s disease, 72 with dementia with Lewy bodies, 49 with progressive supranuclear palsy and 78 with vascular dementia. Subjects with one or more of these neurodegenerative diseases all had higher pneumonia rates, ranging between 50 and 61%, as compared to those without dementia or parkinsonism (40%). In multivariable logistic regression models, male sex and a non-summer death both had independent contributions (ORs of 1.67 and 1.53) towards the presence of pneumonia at autopsy while the absence of parkinsonism or dementia was a significant negative predictor of pneumonia (OR 0.54). Male sex, dementia and parkinsonism may also be risk factors for Covid-19 pneumonia. The apolipoprotein E4 allele, as well as obesity, chronic obstructive pulmonary disease, diabetes, hypertension, congestive heart failure, cardiomegaly and cigarette smoking history, were not significantly associated with pneumonia, in contradistinction to what has been reported for Covid-19 disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by a Covid-19 Supplement to a National Institute on Aging grant (3P30AG019610-20S1). The Brain and Body Donation Program has been supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson Disease Consortium) and the Michael J. Fox Foundation for Parkinson Research. JPM is supported by NIH grants R35 HL135756 and R33 HL137081. Otherwise, no authors received payment or services from a third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Western Institutional Review Board, Puyallup, WA, USAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available on request to thomas.beach@bannerhealth.com